Org Lett by Sato, Michio et al.
Combinatorial Generation of Chemical Diversity by Redox 
Enzymes in Chaetoviridin Biosynthesis
Michio Sato†, Jaclyn M. Winter‡,§, Hiroshi Noguchi†, Yi Tang‡,∥, and Kenji Watanabe*,†
†Department of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan
‡Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, 
California 90095, United States
∥Department of Chemical and Biomolecular Engineering, and Department of Chemistry and 
Biochemistry, University of California, Los Angeles, California 90095, USA
Abstract
Chaetoviridins constitute a large family of structurally related secondary metabolites isolated from 
Chaetomium fungi. To elucidate the biosynthesis pathway and understand how the chemical 
diversity of chaetoviridins is generated, gene deletion and in vitro characterization of the four post-
PKS modifications enzymes were undertaken. CazL and CazP were identified to have substrate 
promiscuity that facilitates the formation of non-chlorinated analogs. In addition, enzymatic 
oxidation and reduction combined with spontaneous dehydration and lactonization of the 
intermediates further expand the chemical diversity.
Chaetoviridins are a group of fungal secondary metabolites produced by various 
Chaetomium spp. that exhibit antifungal and antibiotic activities.1 Initially isolated from C. 
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globosum var. flavo-viride by Takahashi, et al.,2 chaetoviridins and closely related 
chaetomugilins are categorized as azaphilones with a chlorine atom in their chemical 
composition. Those compounds are assembled by iterative polyketide synthases, which are 
megasynthases containing a single set of catalytic domains necessary to carry out a 
polyketide chain extension and modifications that are programmed to function repetitively in 
different combinations. We previously identified the caz biosynthetic gene cluster in C. 
globosum that is responsible for the production of chaetoviridins and chaetomugilins.3 The 
characterization of CazF, a highly-reducing polyketide synthase (HR-PKS), established that 
it acts in both a sequential and a convergent manner with CazM, a nonreducing polyketide 
synthase (NR-PKS), to form the polyketide framework of chaetoviridins and chaetomugilins 
(Figure 1). Through in vitro reconstitution, we demonstrated the production of chaetoviridin 
A 4 from the pyranoquinone intermediate cazisochromene 3 using CazF and an 
acyltransferase CazE,3 as well as the formation of the intermediate cazaldehyde A 1 through 
modular interaction of CazF and CazM.4 However, the post-PKS modifications that lead to 
the generation of chemical diversity among chaetoviridins and chaetomugilins remain poorly 
understood. Here we present the identification and in vitro characterizations of four redox 
enzymes, CazI, CazL, CazP and CazO, that are responsible for chlorination, pyranoquinone 
formation, reduction and oxidation of the polyketide core that give rise to the vast structural 
diversity found in chaetoviridins and chaetomugilins.
First, to fully understand the entire chaetoviridin biosynthetic pathway, we sought to 
determine the function of non-PKS enzymes encoded in the gene cluster. In particular, we 
focused on four redox enzymes, CazI, CazL, CazP and CazO. BLASTP5 search indicated 
CazI as an FADH2-dependent halogenase, CazL as an flavin-containing monooxygenase 
(FMO), CazP as a dehydrogenase and CazO as a flavin-dependent oxidoreductase (Table S2 
and Figure S9 in the Supporting Information).
We initially performed targeted gene deletion by double homologous recombination gene 
replacement using an hph (hygromycin B phosphotransferase gene) cassette on the C. 
globosum ΔCgpyrG/ΔCgligD strain, CGKW14 (Figures S1–S2).6 Four transformants having 
hph integrated individually into cazI, cazL, cazP or cazO were successfully obtained after 
confirming the deletion of the target genes by diagnostic PCR (Figure S3). Five-day culture 
of ΔcazI/CGKW14 grown on MYG liquid medium was extracted with ethyl acetate, and the 
dried extract was subjected to metabolite analysis by liquid chromatography–mass 
spectrometry (LCMS). As expected, deletion of cazI resulted in an accumulation of 1, the 
predicted substrate for halogenation by CazI (Figure S10a). Similarly, deletion of cazL led to 
an accumulation of 2, the proposed substrate of CazL (Figure S10b). The chemical 
structures of all the compounds isolated from the knockout mutants were characterized by 
high-resolution (HR) electrospray ionization (ESI) LCMS, 1H NMR and 13C NMR (Table 
S3 and S4, Figures S14–S21).
As to the remaining two genes, the UV trace from HPLC analysis of the extract from ΔcazP/
CGKW14 (Figure S10c) showed a nearly complete loss of the formation of chaetoviridin B 
6 (Table S7 and Figures S29–S30) and an accumulation of 4'-epi-N-2-hydroxyethyl-
azachaetovoridin A 76 (Table S8 and Figures S31, S32). Since 6 could form spontaneously 
from chaetoviridin C 8, the depletion of 6 suggests that the production of 8 is lost in this 
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mutant. Similarly, the accumulation of 7 suggests 4 is what is collecting in the absence of 
CazP. Similarly, the UV trace from HPLC analysis of the extract from ΔcazO/CGKW14 
(Figure S10d) showed a significant loss of 4 (Table S5 and Figures S22– S23) and an 
accumulation of 8 (Table S9 and Figures S33– S34). Combined, these results suggest that 
the predicted dehydrogenase CazP is responsible for the reduction of 4 to 8, and the 
predicted oxidase CazO catalyzes the oxidation of 8 to form 4.
Preparation of the deletion strains gave us insight into the biosynthetic mechanisms involved 
in the formation of chaetoviridins and chaetomugilins, but they also provided us with 
intermediates in the biosynthetic pathway that can be used as substrates in more detailed in 
vitro assays. All of such intermediates were characterized by NMR analyses as described in 
the Supporting information. Among the intermediates isolated in this study, 2 and 5 were 
new compounds.
To characterize in detail the biochemical function of CazI, we cloned cazI from mRNA 
extracted from C. globosum, and expressed it heterologously in Escherichia coli (Figures S4 
and S6). CazI showed a high amino acid sequence similarity to the previously characterized 
flavin-dependent halogenase RadH (70% positives, 54% identities) from the radicicol 
biosynthetic pathway in C. chiversii.7 Therefore, the predicted halogenase activity of CazI 
was examined in vitro using 1 that was isolated from the culture of ΔcazI/CGKW14 as a 
substrate. As predicted, the purified recombinant CazI was able to catalyze the halogenation 
of 1 to form 2 (Figure 2a i vs. ii).
Next, we attempted to characterize the activity of the predicted FMO, CazL. We speculated 
that CazL would be responsible for the formation of the pyranoquinone based on the amino 
acid sequence similarity to AfoD8 (73% positives, 55% identities) and AzaH9 (57% 
positives, 41% identities) from the asperfuranone and the azanigerone biosynthetic pathway, 
respectively, that are responsible for the pyran ring formation on substrates that are highly 
similar to 1. We cloned cazL from C. globosum mRNA, and expressed it heterologously in 
Saccharomyces cerevisiae (Figures S5 and S7). The recombinant CazL was subjected to an 
in vitro assay using 2 as a substrate, and we were able to confirm that CazL was responsible 
for the pyranoquinone formation (Figure 2b i vs. ii). Interestingly, however, CazL was also 
able to accept the non-chlorinated compound 1 as a substrate (Figure 2b iii vs. vi) to form a 
pyranoquinone-containing product 5 (Table S6 and Figures S24–S28). The chemical 
structures of all of the products from the in vitro assays that were previously uncharacterized 
were elucidated by HRESIMS, 1H NMR and 13C NMR. These results indicate that CazL 
tolerates lack of chlorination at the C6 position of the aromatic ring in its substrate. To 
understand the substrate preference of CazL, kinetic constants for the two substrates 2 and 1 
were determined from initial velocity measurements. CazL displayed a kcat of 51.58 ± 7.80 
min−1 for the formation of 3 with a Km of 68.12 ± 22.10 μM for 2, whereas a similar kcat of 
30.88 ± 2.30 min−1 for the formation of 5 and a Km of 73.04 ± 9.93 μM were obtained when 
1 was used as the substrate (Figure S11). These results suggest that CazL catalyzes the 
transformation of the halogenated substrate only about two-fold more efficiently than the 
non-halogenated precursor. Considering that CazL would also have to compete with CazI for 
1, the predominant product formed by CazL would be 3. However, the observed sizable 
activity of CazL against 1 can explain the low-level but actual formation of non-halogenated 
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chaetoviridin H 1010 and chaetomugilin U 11.11 This type of relaxed substrate specificity is 
rather common among secondary metabolite biosynthetic enzymes and serves as the basis 
for the chemical diversity generation of natural products.12 Our study demonstrated that this 
is also the case for the biosynthesis of chaetoviridins and chaetomugilins.
For the in vitro characterization of CazP, we heterologously expressed the cloned cazP in E. 
coli (Figure S4 and S6). When the recombinant CazP was provided with 4 and NADPH, we 
observed the formation of 8 (Figure 3a i vs. ii), indicating that CazP is responsible for the 
reduction of the C8–C2' olefin of 4. However, we also found the formation of 6. As stated 
earlier, we hypothesized that 8 could be converted into 6 through a spontaneous 
rearrangement, which can be initiated by a hydrolytic opening of the δ-lactone ring and a 
rotation of the molecule around the C8–C2' bond. Subsequent tetrahydrofuran ring 
formation followed by a dehydrative cyclization of the terminal polyketide chain into a δ-
lactone can yield 6 (Figure 3b). To confirm the spontaneous transformation of 8 into 6, we 
followed a HEPES solution of 8 at a neutral pH kept at room temperature. From this 
experiment, we were able to establish that 8 indeed converted to 6 spontaneously (Figure 
S12). Furthermore, we suspect that the lactonized product 6 could be oxidized by an 
unidentified enzyme to form the hydroxylated compound, chaetomugilin A 12.3 At this 
point, based on the previously observed lack of discrimination between halogenated and 
non-halogenated substrates by CazL, we speculated that CazP may also accept 10.13 Like 
other substrates used in this study, 10 was isolated from the wild-type C. globosum (Table 
S10 and Figures S13a, S35, S36) as a substrate and forms a reduced product. Our in vitro 
assay proved this to be the case (Figure 3c); CazP accepted 10 as a substrate to form 13 
(Figure S13c). We also observed the formation of 11 (Figure S13b), a presumed product of 
the spontaneous lactonization of 13.
To characterize CazO in detail, we produced the protein recombinantly in S. cerevisiae using 
the cazO gene cloned from C. globosum mRNA (Figure S5 and S8). Then, the activity of the 
recombinant CazO was examined in an in vitro assay using 8 isolated from the ΔcazO/
CGKW14 strain (Figure S10d) as a substrate. In the absence of CazO, the substrate 
completely transformed into 6 spontaneously. However, when the active sample of CazO 
was provided in the reaction mixture, we observed the formation of the oxidized product 4 in 
addition to the spontaneously forming 6 (Figure 3d). We suspect that chaetoviridin E 913 can 
be formed from 4 via dehydration catalyzed by an unknown enzyme. Similarly, 7 can be 
formed readily by ethanolamine attacking 4.14
In this study, we combined targeted gene deletion studies and in vitro assays to identify the 
main pathway leading to the formation of chaetoviridins through the formation of 
cazisochromene 3 and chaetoviridin A 4 (Figure 1). Through the study, we identified seven 
of the intermediates formed and the four enzymes, CazI, CazL, CazP and CazO, responsible 
for the chlorination and oxidation steps involved in the transformation of 1 to 4. We also 
discovered the unanticipated relaxed substrate tolerance of the FMO CazL that allowed 
formation of non-chlorinated products. This finding led us to discover the same chlorination-
insensitive substrate specificity of the dehydrogenase CazP. Our current study further adds to 
the notion that relaxed substrate specificity in the post-PKS modification redox enzymes is 
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key to the generation of chemical diversity in natural product biosynthesis.15,16 In addition, 
combination of enzymatic oxidation and reduction with spontaneous conversion of the core 
chemical framework via dehydration and lactonization further expands the variety of 
chaetoviridin and chaetomugilin analogs being formed. These mechanisms underlie the 
occurrence of a large number of variants, 43 to date,1 of this class of compounds.
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Figure 1. 
Chemical diversity of post-PKS assembly modifications in the chaetoviridin biosynthetic 
pathway. Proposed biosynthesis of chaetoviridin A (4), 4'-epi-N-2-hydroxyethyl-
azachaetoviridin A (7), chaetomugilin U (11) and chaetomugilin A (12). Domain 
abbreviations: ketosynthase (KS), malonyl-CoA:acyl carrier protein acyltransferase (MAT), 
dehydratase (DH), methyltransferase (MT), enoyl reductase (ER), ketoreductase (KR), acyl 
carrier protein (ACP), starter-unit:ACP-transacylase (SAT), product template (PT) and 
reductive (R) domain.
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Figure 2. 
In vitro characterization of CazI and CazL. (a) HPLC analysis of CazI using 1 as a substrate. 
HPLC traces were monitored at 254 nm. (i) Negative control with 1 lacking CazI. (ii) 
Reaction containing CazI and 1 incubated for 16 h at room temperature. (iii) Authentic 
reference of 2. (b) HPLC analysis of CazL using 2 and 1 as substrates. HPLC traces were 
monitored at 280 nm. (i) Negative control with 2 lacking CazL. (ii) Reaction containing 
CazL and 2 after 1 h at 30 °C. (iii) Negative control with 1 lacking CazL. (iv) Reaction 
containing CazL and 1 incubated for 1 h at 30 °C.
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Figure 3. 
HPLC analyses of in vitro assays on CazP and CazO. All HPLC traces were monitored at 
280 nm. (a) In vitro characterization of CazP using 4 as a substrate. (i) Negative control with 
4 lacking CazP. (ii) Reaction containing CazP and 4 incubated for 15 min at 30 °C. 
Authentic references of (iii) 4, (iv) 6 and (v) 8 are also shown. (b) Proposed reaction 
mechanism of lactonization from 4 in 6 via 8 by CazP. (c) In vitro characterization of CazP 
using 10 as a substrate. (i) Negative control with 10 lacking CazP. (ii) Reaction containing 
CazP and 10 incubated for 3 h at 30 °C. (d) In vitro characterization of CazO using 8 as a 
substrate. (i) Negative control with 8 lacking CazO. Most of 8 has converted into 6 
spontaneously in the reaction mixture. (ii) Reaction containing CazO and 8 incubated for 1 h 
at 30 °C.
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